222 related articles for article (PubMed ID: 24616881)
1. Development of a mouse model of menopausal ovarian cancer.
Smith ER; Wang Y; Xu XX
Front Oncol; 2014; 4():36. PubMed ID: 24616881
[TBL] [Abstract][Full Text] [Related]
2. White spotting variant mouse as an experimental model for ovarian aging and menopausal biology.
Smith ER; Yeasky T; Wei JQ; Miki RA; Cai KQ; Smedberg JL; Yang WL; Xu XX
Menopause; 2012 May; 19(5):588-96. PubMed ID: 22228319
[TBL] [Abstract][Full Text] [Related]
3. Global deletion of Trp53 reverts ovarian tumor phenotype of the germ cell-deficient white spotting variant (Wv) mice.
Cai KQ; Wang Y; Smith ER; Smedberg JL; Yang DH; Yang WL; Xu XX
Neoplasia; 2015 Jan; 17(1):89-100. PubMed ID: 25622902
[TBL] [Abstract][Full Text] [Related]
4. Follicle Depletion Provides a Permissive Environment for Ovarian Carcinogenesis.
Wang Y; Cai KQ; Smith ER; Yeasky TM; Moore R; Ganjei-Azar P; Klein-Szanto AJ; Godwin AK; Hamilton TC; Xu XX
Mol Cell Biol; 2016 Sep; 36(18):2418-30. PubMed ID: 27354067
[TBL] [Abstract][Full Text] [Related]
5. Explicit targeting of transformed cells by VSV in ovarian epithelial tumor-bearing Wv mouse models.
Capo-chichi CD; Yeasky TM; Heiber JF; Wang Y; Barber GN; Xu XX
Gynecol Oncol; 2010 Feb; 116(2):269-75. PubMed ID: 19932656
[TBL] [Abstract][Full Text] [Related]
6. Oocyte growth and follicular development in KIT-deficient Fas-knockout mice.
Moniruzzaman M; Sakamaki K; Akazawa Y; Miyano T
Reproduction; 2007 Jan; 133(1):117-25. PubMed ID: 17244738
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-1 inhibition prolongs postnatal ovarian follicle lifespan in mice.
Smith ER; Yang WL; Yeasky T; Smedberg J; Cai KQ; Xu XX
Biol Reprod; 2013 Oct; 89(4):103. PubMed ID: 23966321
[TBL] [Abstract][Full Text] [Related]
8. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm.
Kurman RJ; Shih IeM
Hum Pathol; 2011 Jul; 42(7):918-31. PubMed ID: 21683865
[TBL] [Abstract][Full Text] [Related]
9. Spatiotemporal changes in mechanical matrisome components of the human ovary from prepuberty to menopause.
Ouni E; Bouzin C; Dolmans MM; Marbaix E; Pyr Dit Ruys S; Vertommen D; Amorim CA
Hum Reprod; 2020 Jun; 35(6):1391-1410. PubMed ID: 32539154
[TBL] [Abstract][Full Text] [Related]
10. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory.
Kurman RJ; Shih IeM
Am J Surg Pathol; 2010 Mar; 34(3):433-43. PubMed ID: 20154587
[TBL] [Abstract][Full Text] [Related]
11. A reduction of cyclooxygenase 2 gene dosage counters the ovarian morphological aging and tumor phenotype in Wv mice.
Yang WL; Cai KQ; Smedberg JL; Smith ER; Klein-Szanto A; Hamilton TC; Xu XX
Am J Pathol; 2007 Apr; 170(4):1325-36. PubMed ID: 17392171
[TBL] [Abstract][Full Text] [Related]
12. NTP Toxicology and Carcinogenesis Studies of Nitrofurantoin (CAS No. 67-20-9) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1989 Sep; 341():1-218. PubMed ID: 12724784
[TBL] [Abstract][Full Text] [Related]
13. Origin and molecular pathogenesis of ovarian high-grade serous carcinoma.
Kurman RJ
Ann Oncol; 2013 Dec; 24 Suppl 10():x16-21. PubMed ID: 24265397
[TBL] [Abstract][Full Text] [Related]
14. Mutant p53 Promotes Epithelial Ovarian Cancer by Regulating Tumor Differentiation, Metastasis, and Responsiveness to Steroid Hormones.
Ren YA; Mullany LK; Liu Z; Herron AJ; Wong KK; Richards JS
Cancer Res; 2016 Apr; 76(8):2206-18. PubMed ID: 26964623
[TBL] [Abstract][Full Text] [Related]
15. Proliferation and differentiation of spermatogonial stem cells in the w/wv mutant mouse testis.
Ohta H; Tohda A; Nishimune Y
Biol Reprod; 2003 Dec; 69(6):1815-21. PubMed ID: 12890724
[TBL] [Abstract][Full Text] [Related]
16. Chromosome 3 anomalies investigated by genome wide SNP analysis of benign, low malignant potential and low grade ovarian serous tumours.
Birch AH; Arcand SL; Oros KK; Rahimi K; Watters AK; Provencher D; Greenwood CM; Mes-Masson AM; Tonin PN
PLoS One; 2011; 6(12):e28250. PubMed ID: 22163003
[TBL] [Abstract][Full Text] [Related]
17. Gonadotropin-releasing hormone agonist suppression of ovarian tumorigenesis in mice of the Wx/Wv genotype.
Blaakaer J; Baeksted M; Micic S; Albrectsen P; Rygaard J; Bock J
Biol Reprod; 1995 Oct; 53(4):775-9. PubMed ID: 8547469
[TBL] [Abstract][Full Text] [Related]
18. A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development.
Sherman-Baust CA; Kuhn E; Valle BL; Shih IeM; Kurman RJ; Wang TL; Amano T; Ko MS; Miyoshi I; Araki Y; Lehrmann E; Zhang Y; Becker KG; Morin PJ
J Pathol; 2014 Jul; 233(3):228-37. PubMed ID: 24652535
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of claudin family proteins in mouse ovarian serous papillary epithelial adenoma in aging FSH receptor-deficient mutants.
Aravindakshan J; Chen X; Sairam MR
Neoplasia; 2006 Dec; 8(12):984-94. PubMed ID: 17217615
[TBL] [Abstract][Full Text] [Related]
20. Incidence and distribution of experimental metastases in mutant mice with defective organ microenvironments (genotypes Sl/Sld and W/Wv).
Arguello F; Furlanetto RW; Baggs RB; Graves BT; Harwell SE; Cohen HJ; Frantz CN
Cancer Res; 1992 Apr; 52(8):2304-9. PubMed ID: 1559233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
